Speciality European Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSpeciality European Pharma

Speciality European Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Plenaxis	Abarelix	2003-11-25		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

prostatic neoplasms

,

Aglatimagene besadenovec

,

breast neoplasms

,

ovarian neoplasms

,

triple negative breast neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

bites and stings

,

prostatic neoplasms

allergic rhinitis seasonal

,

nasal obstruction

,

,

,

restless legs syndrome

,

spinal cord injuries

,

type 1 diabetes mellitus

,

,

non-small-cell lung carcinoma

,

,

breast neoplasms

,

,

neurologic manifestations

,

wounds and injuries

,

central nervous system diseases

,

spinal cord diseases

,

sleep wake disorders

,

inguinal hernia

,

peripheral nervous system diseases

,

,

,

,

healthy volunteers/patients

,

,

partial epilepsies

,

diabetic neuropathies

,

,

,

sleep initiation and maintenance disorders

,

,

postherpetic neuralgia

,

postoperative pain

,

anxiety disorders

,

,

generalized anxiety disorder

,

complex partial epilepsy

,

,

,

bronchiolitis obliterans syndrome

,

,

,

intractable pain

,

,

,

renal insufficiency

,

pharmacovigilance

urologic neoplasms

,

,

,

,

plasma cell neoplasms

,

,

,

respiratory tract diseases

,

pleural effusion

,

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

neoplasms by site

,

malignant pleural effusion

,

pleural diseases

,

pleural neoplasms

,

squamous cell carcinoma of head and neck

,

cutaneous malignant melanoma

,

,

stomach neoplasms

,

ovarian neoplasms

,

kidney transplantation

,

graft rejection

,

psychology rejection

,

male breast neoplasms

,

uveal neoplasms

,

,

hodgkin disease

,

pancreatic ductal carcinoma

,

serous cystadenocarcinoma

,

,

ovarian epithelial carcinoma

,

,

adenocarcinoma of lung

,

bronchiolo-alveolar adenocarcinoma

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

endometrial neoplasms

,

merkel cell carcinoma

,

head and neck neoplasms

,

triple negative breast neoplasms

,

,

type 2 diabetes mellitus

,

breast neoplasms

,

non-small-cell lung carcinoma

,

diabetes mellitus

,

,

rheumatoid arthritis

,

colorectal neoplasms

,

neoplasm metastasis

,

multiple myeloma

,

,

,

,

liver neoplasms

,

,

hepatocellular carcinoma

,

transitional cell carcinoma

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

myeloid leukemia chronic-phase

,

,

chronic hepatitis b

,

chronic hepatitis

,

,

,

juvenile arthritis

,

esophageal neoplasms

,

wasting syndrome

,

,

,

urinary bladder neoplasms

,

rectal neoplasms

,

cardiovascular diseases

,

lymphoid leukemia

,

acute coronary syndrome

,

,

atrial fibrillation

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia accelerated phase

,

lupus nephritis

,

systemic lupus erythematosus

,

giant cell arteritis

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

,

,

colonic neoplasms

,

,

,

brain neoplasms

,

,

bipolar disorder

,

sjogren's syndrome

,

prostatic neoplasms

,

hematologic neoplasms

,

primary myelofibrosis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use